Downregulation of glutamic-oxaloacetic transaminase 2 (GOT2) activates oxidative stress in human pancreatic ductal adenocarcinoma (PDAC) cells and inhibits the proliferation of pancreatic cancer (Yang et al., 2018). Here, GOT2 is linked to pancreatic ductal adenocarcinoma.